News Sentiment

GHRS sentiment intelligence

GH Research PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 28.71 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

75/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+8.3% over one week, +29.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Price-Driven Insight from (GHRS) for Rule-Based Strategy

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 75/100 classification
One-week reaction 8.3% Price confirming higher
Trend fit Trend active 29.1% over four weeks
Fair value 136.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 33
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 9
Investing.com 4
Stock Traders Daily 3
TradingKey 3
GlobeNewswire 3
Benzinga 2
Sahm 2

Event Lens

What the news is about

Classified themes
Earnings 23
Market update 17
Analyst action 4
Guidance 3
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
Stock Traders Daily Direct company coverage

Price-Driven Insight from (GHRS) for Rule-Based Strategy

This article provides a price-driven analysis of Gh Research Plc (NASDAQ: GHRS) for developing a rule-based trading strategy. It highlights strong sentiment supporting an overweight bias and identifies key support and resistance levels across multiple time horizons. The analysis

Tone
Positive 78/100
Event
Market update
Published
19 Jul 2026 00:46
Source
Stock Traders Daily
24/7 Wall St. Direct company coverage

GH Research : GHRS

This article provides an overview of GH Research PLC (GHRS), a Dublin-based biopharmaceutical company specializing in treatments for psychiatric and neurological disorders using 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies, particularly for treatment-resistant depressio

Tone
Positive 67/100
Event
Market update
Published
17 Jul 2026 16:11
Source
24/7 Wall St.
Benzinga Direct company coverage

Why Is GH Research Stock Trading Higher on Thursday?

GH Research (GHRS) stock is trading higher due to Eli Lilly's agreement to acquire AtaiBeckley Inc. (ATAI) for up to $3.8 billion. GH Research's lead drug, GH001, is being compared to AtaiBeckley’s BPL-003, both targeting treatment-resistant depression with similar active compoun

Tone
Positive 66/100
Event
Market update
Published
16 Jul 2026 16:41
Source
Benzinga
Sahm Direct company coverage

GH Research (GHRS) In Focus As FDA Psychedelic Shift Raises The Question Of Value

The FDA's recent guidance on psychedelic drug development has significantly boosted GH Research (GHRS) stock, with its share price up over 100% year-to-date. Despite this surge, the company's valuation, evidenced by a 7x price-to-book ratio, appears expensive compared to its peer

Tone
Neutral 50/100
Event
Guidance
Published
16 Jul 2026 11:42
Source
Sahm
Market source Direct company coverage

GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS)

GH Research (GHRS) shares rose about 12% following reports that Eli Lilly is discussing acquiring Atai Life Sciences (ATAI), a psychedelic drug developer. This news boosted the entire psychedelic medicines sector, as investors anticipate increased pharmaceutical interest in such

Tone
Positive 77/100
Event
Deals and strategy
Published
16 Jul 2026 10:33
Source
Market source
MSN Direct company coverage

GH Research (GHRS) price target increased by 18.94% to 40.04

This article reports a significant increase in the price target for GH Research (GHRS), which has been raised by 18.94% to $40.04. This adjustment indicates a positive outlook from analysts regarding the company's future stock performance.

Tone
Positive 75/100
Event
Guidance
Published
10 Jul 2026 16:09
Source
MSN
TradingView Direct company coverage

A3CUAZ Forecast — Price Target — Prediction for 2027

This article provides a forecast for GH Research Plc (A3CUAZ) stock, including analyst price targets and ratings. It states that 8 analysts offer a 1-year price forecast, with current price, historical performance, and future earning estimates. The article also answers frequently

Tone
Positive 64/100
Event
Analyst action
Published
10 Jul 2026 09:40
Source
TradingView
TradingView Direct company coverage

Price to book forward of GH Research PLC – NASDAQ:GHRS

This article from TradingView presents the "Price to book forward" financial metric for GH Research PLC (NASDAQ:GHRS). It provides financial data and other information related to the company's stock performance. The content is primarily a data presentation page on the TradingView

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 16:41
Source
TradingView
TradingView Direct company coverage

Price to sales forward of GH Research PLC – NASDAQ:GHRS

This article focuses on the "Price to sales forward" metric for GH Research PLC (NASDAQ: GHRS) within the financial analysis section of TradingView. It provides specific financial data for the company, indicating the period, value, change, and percentage change for this particula

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 15:12
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of GH Research PLC – NASDAQ:GHRS

This article provides financial data specifically on the enterprise value to revenue forward of GH Research PLC (NASDAQ:GHRS). It appears to be a stub or data-point focused entry, offering a snapshot of a particular financial metric for the company. The content primarily presents

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 11:43
Source
TradingView
Finviz Direct company coverage

GHRS - GH Research PLC Options

This article provides a comprehensive financial overview of GH Research PLC (GHRS), detailing its stock performance, key financial metrics, and insider/institutional ownership. It highlights the company's recent closing price, market capitalization, earnings per share, and variou

Tone
Positive 61/100
Event
Earnings
Published
04 Jul 2026 02:09
Source
Finviz
TradingView Direct company coverage

GH Research Plc Actuals & Estimates (FWB:1KA)

This article provides financial actuals and estimates for GH Research Plc (FWB:1KA), including income statement, balance sheet, cash flow, and valuation metrics. It highlights analyst price targets, historical stock data, upcoming earnings reports, and details on recent earnings

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 03:10
Source
TradingView
富途牛牛 Direct company coverage

Pre-Market Movement | GH Research Shares Surge to 52-Week High

GH Research shares experienced a significant surge in pre-market trading, reaching a new 52-week high of $12.37. This substantial increase was driven by the company's positive announcement regarding its GH001 program for treating depression, which reported an 87.5% remission rate

Tone
Positive 93/100
Event
Market update
Published
27 Jun 2026 13:10
Source
富途牛牛
TradingView Direct company coverage

GHRS Forecast — Price Target — Prediction for 2027

The article provides a forecast and price target for GH Research PLC (GHRS) stock, indicating a price target of $39.13 based on analyst reports. It details the company's recent stock performance, noting a significant increase over the past year, and includes analyst estimates for

Tone
Positive 65/100
Event
Analyst action
Published
26 Jun 2026 20:39
Source
TradingView
Stock Traders Daily Direct company coverage

(GHRS) Price Dynamics and Execution-Aware Positioning

This article analyzes the price dynamics and execution-aware positioning for Gh Research Plc (NASDAQ: GHRS). It highlights strong near-term sentiment, potential for higher levels, and no resistance above the current price, suggesting upside potential. The report also details thre

Tone
Positive 71/100
Event
Market update
Published
26 Jun 2026 16:39
Source
Stock Traders Daily
Investing.com Direct company coverage

GH Research PLC stock hits 52-week high at 25.98 USD

GH Research PLC stock has reached a new 52-week high of $25.98, reflecting a 104% increase over the past year and strong investor confidence. The company, valued at $1.77 billion, recently reported positive Phase 2a trial results for its inhaled mebufotenin (GH001) in postpartum

Tone
Positive 72/100
Event
Earnings
Published
26 Jun 2026 15:10
Source
Investing.com
Stock Titan Direct company coverage

GH Research PLC (GHRS) re-elects directors and ratifies PwC Ireland at AGM

GH Research PLC announced the results of its annual general meeting held on June 25, 2026. Shareholders approved all resolutions, including the re-election of four directors—Florian Schönharting, Michael Forer, Dermot Hanley, and Duncan Moore—and the ratification of Pricewaterhou

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 11:10
Source
Stock Titan
TradingView Direct company coverage

GH Research Plc Actuals & Estimates (MUN:1KA)

This article provides an overview of GH Research Plc (MUN:1KA) financial actuals and estimates, including its stock ticker, analyst price forecasts, historical price performance, and upcoming earnings dates. It details recent earnings and revenue figures, notes that the company d

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 15:42
Source
TradingView
TradingKey Direct company coverage

GH Research PLC (GHRS) Valuation: PE, PB & Fair Value Analysis

This article from TradingKey provides a valuation analysis for GH Research PLC (GHRS). It notes that relevant data for key valuation metrics such as P/E, P/B, P/S, and P/CF have not yet been disclosed by the company. The article focuses on the current stock price and market capit

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:40
Source
TradingKey
TradingKey Direct company coverage

GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for GH Research PLC (GHRS), highlighting analyst ratings and target prices. Based on 9 analysts, the company has a "Buy" rating with a target price of $39.50, representing a 97.70% upside. It also details past and future EPS expectations

Tone
Positive 71/100
Event
Earnings
Published
18 Jun 2026 02:09
Source
TradingKey
Simply Wall Street Direct company coverage

What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders

GH Research (GHRS) has reported positive Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all ten patients and a favorable safety profile. This breakthrough strengthens the company's investment narrative for a niche psychia

Tone
Positive 66/100
Event
Earnings
Published
17 Jun 2026 22:40
Source
Simply Wall Street
TradingKey Direct company coverage

GH Research PLC (GHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown of GH Research PLC (GHRS) by business segments and regional contributions. However, it explicitly states that the relevant financial data has not yet been disclosed by the company. As a result, the content indicates that no specific rev

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 10:39
Source
TradingKey
Stock Traders Daily Direct company coverage

(GHRS) as a Liquidity Pulse for Institutional Tactics

This article provides an analysis of Gh Research Plc (NASDAQ: GHRS) using AI models, outlining a weak near and mid-term sentiment but a strong long-term outlook. It details three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target,

Tone
Neutral 50/100
Event
Guidance
Published
15 Jun 2026 15:02
Source
Stock Traders Daily